Oaktree Capital Management’s Intelligent Medicine Acquisition Corp. Class A Common Stock IQMD Stock Holding History

Oaktree Capital Management’s Portfolio IQMD Stock Details IQMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-100,000	Closed	-$1.03M	–	365
2022 Q4	$1.03M	Hold	100,000	–	–	0.01%	310
2022 Q3	$1.01M	Hold	100,000	–	–	0.01%	337
2022 Q2	$1M	Hold	100,000	–	–	0.01%	318
2022 Q1	$999K	Hold	100,000	–	–	0.01%	307
2021 Q4	$990K	Buy	+100,000	New	+$988K	0.01%	305

Other funds holding IQMD

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return

Walleye Trading New York $60B AUM 42.19% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Oaktree Capital Management's IQMD Position: Q1 2023 in Review

Oaktree Capital Management sold out of Intelligent Medicine Acquisition Corp. Class A Common Stock (IQMD) in Q1 2023, closing a stake of 100,000 shares — an estimated $1.03M sold.

Oaktree Capital Management first reported a position in IQMD in Q4 2021 and held it in 5 quarters. The position peaked at $1.03M in Q4 2022. 8 funds tracked by Wall St. Rank hold IQMD as of Q1 2023.

Oaktree Capital Management reported no remaining Intelligent Medicine Acquisition Corp. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
Oaktree Capital Management sold 100,000 Intelligent Medicine Acquisition Corp. Class A Common Stock shares in Q1 2023, an estimated $1.03M.
Oaktree Capital Management first reported a position in Intelligent Medicine Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 5 quarters.
Oaktree Capital Management's Intelligent Medicine Acquisition Corp. Class A Common Stock position peaked at $1.03M in Q4 2022.
8 funds tracked by Wall St. Rank held Intelligent Medicine Acquisition Corp. Class A Common Stock as of Q1 2023.

Based on Oaktree Capital Management's 13F filing for Q1 2023, filed 15 May 2023.